28. Malignant pleural mesothelioma - A literature review and case report

Cung Van Cong

Main Article Content

Abstract

Mesothelioma is a type of tumor arising from the mesothelial cells lining body cavities including the pleura, pericardium, peritoneum, and vagina. Most Malignant Pleural Mesothelioma (MPM) occur in the chest and are often related to a history of asbestos exposure. The 2015 WHO classification (updated 2021), MPM is divided into 3 groups (under the subtype): Epithelioid Mesothelioma (EM); Sarcomatoid Mesothelioma (SM) and mixed form. The diagnosis of MPM is challenging and there are many “traps”, especially in small biopsies. Recently, thanks to the development of immunohistochemistry, the definitive diagnosis has made many advances. Computed tomography of the chest helps guide the diagnosis and biopsy of the lung and pleura; Thoracic surgery can be used with the goal of obtaining diagnostic specimens and providing palliative treatment. We report a case of MPM, SM type confirmed by pathology and immunohistochemical staining at the National Lung Hospital. This review highlights what physicians need to know regarding the clinical presentation, radiographs, and histological features, as well as recent advances in immunohistochemistry in the diagnosis of this disease.

Article Details

References

1. Eccher A, Girolami I, Lucenteforte E, et al. Diagnostic mesothelioma biomarkers in effusion cytology. Cancer Cytopathol. 2021 Jul;129(7):506-516. doi: 10.1002/cncy.22398. Epub 2021 Jan 19.PMID: 33465294 .
2. Beasley MB, Galateau-Salle F, Dacic S. Pleural mesothelioma classification update. Virchows Arch. 2021 Jan;478(1):59-72. doi: 10.1007/s00428-021-03031-7. Epub 2021 Jan 21.PMID: 33475835.
3. Dacic S. Pleural mesothelioma classification-update and challenges. Mod Pathol. 2022 Jan;35(Suppl 1):51-56. doi: 10.1038/s41379-021-00895-7. Epub 2021 Aug 31. PMID: 34465883.
4. Oramas DM, Zaleski M, Moran CA. Sarcomatoid Mesothelioma: A Clinicopathological and Immunohistochemical Study of 64 Cases. Int J Surg Pathol. 2021 Dec;29(8):820-825. doi: 10.1177/10668969211014256. Epub 2021 May 3.PMID: 33939493.
5. Fels Elliott DR, Jones KD. Diagnosis of Mesothelioma. Surg Pathol Clin. 2020 Mar;13(1):73-89. doi: 10.1016/j.path.2019.10.001. Epub 2019 Dec 3. PMID: 32005436.
6. Itano H, Takeda T, Yamada T, et al. Heterologous sarcomatoid pleural mesothelioma with osteosarcomatous differentiation: Heterologous sarcomatoid pleural mesothelioma with osteosarcomatous differentiation: A report of autopsy case that accomplished trimodality therapy and review of the literature. Gen Thorac Cardiovasc Surg. 2020 Aug;68(8):871-879. doi: 10.1007/s11748-019-01182-8. Epub 2019 Aug 1.PMID: 31372931.
7. Chen KB, Huang YJ, Huang Y, et al. Metastasis of sarcomatoid malignant mesothelioma with p16/CDKN2A deletion manifested as a subcutaneous mass in the back: A case report and review of literature. Int J Surg Pathol. 2021 Dec;29(8):856-863. doi: 10.1177/10668969211005094. Epub 2021 Mar 17.PMID: 33729861.
8. Galetta D, Catino A, Misino A, et al. Sarcomatoid mesothelioma: future advances in diagnosis, biomolecular assessment, and therapeutic options in a poor-outcome disease. Tumori. 2016 Mar-Apr;102(2):127-30. doi: 10.5301/tj.5000364. Epub 2015 Jun 5.PMID: 26108245.
9. Zaleski M, Kalhor N, Fujimoto J, et al. Sarcomatoid mesothelioma: A CDKN2A molecular analysis of 53 cases with immunohistochemical correlation with BAP1. Pathol Res Pract. 2020 Dec;216(12):153267. doi: 10.1016/j.prp.2020.153267. Epub 2020 Nov 2.PMID: 33176261.
10. Nishikubo M, Jimbo N, Tanaka Y, Tachihara M, Itoh T, Maniwa Y. Sarcomatoid mesothelioma originating from mesothelioma in situ: are methylthioadenosine phosphorylase loss and CDKN2A homozygous deletion poor prognostic factors for preinvasive mesothelioma? Virchows Arch. 2022 Jan 19. doi: 10.1007/s00428-022-03281-z. Online ahead of print.PMID: 35043235.
11. Atre ID, Watane GV, Harisinghani MG. Malignant peritoneal mesothelioma: correlation between CT imaging features and histologic subtypes. Abdom Radiol (NY). 2021 Nov;46(11):5105-5113. doi: 10.1007/s00261-021-03231-4. Epub 2021 Aug 3. PMID: 34342707.
12. Paajanen J, Laaksonen S, Ilonen I, et al. Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival. Lung Cancer. 2018 Feb;116:73-79. doi: 10.1016/j.lungcan.2018.01.001. Epub 2018 Jan 4. PMID: 29413055.
13. Ciarallo A, Makis W, Novales-Diaz JA, et al. Sarcomatoid carcinoma (carcinosarcoma) of the lung mimics malignant pleural mesothelioma on 18F-FDG PET/CT: a report of 2 cases. Clin Nucl Med. 2012 Apr;37(4):416-9. doi: 10.1097/RLU.0b013e31823ea47f.PMID: 22391723.
14. Kim S, Bull DA, Garland L, et al .Is there a role for cancer-directed surgery in early-stage sarcomatoid or biphasic mesothelioma? Ann Thorac Surg. 2019 Jan;107(1):194-201. doi: 10.1016/j.athoracsur.2018.07.081. Epub 2018 Sep 29.PMID: 30278171.